BIOTECH ON THE MOVE! We are on the Nasdaq at the right time for mine.
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billionAbbVie's announcement of its $10.1 billion acquisition of cancer drug developer ImmunoGen led to a significant surge in Biotech Stocks.